1. Home
  2. CYTK vs IAG Comparison

CYTK vs IAG Comparison

Compare CYTK & IAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$56.27

Market Cap

7.8B

Sector

Health Care

ML Signal

N/A

Logo Iamgold Corporation

IAG

Iamgold Corporation

N/A

Current Price

$17.37

Market Cap

8.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
IAG
Founded
1997
1990
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.8B
IPO Year
2004
2002

Fundamental Metrics

Financial Performance
Metric
CYTK
IAG
Price
$56.27
$17.37
Analyst Decision
Buy
Buy
Analyst Count
22
14
Target Price
★ $109.42
$22.79
AVG Volume (30 Days)
1.9M
★ 5.0M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $13,368,000.00
N/A
Revenue This Year
$87.17
$30.17
Revenue Next Year
$170.90
$8.51
P/E Ratio
★ N/A
$18.66
Revenue Growth
N/A
★ N/A
52 Week Low
$53.58
$12.63
52 Week High
$88.31
$24.87

Technical Indicators

Market Signals
Indicator
CYTK
IAG
Relative Strength Index (RSI) 38.80 47.64
Support Level N/A $16.17
Resistance Level $66.62 $18.89
Average True Range (ATR) 2.69 0.78
MACD -0.24 0.15
Stochastic Oscillator 24.29 46.10

Price Performance

Historical Comparison
CYTK
IAG

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About IAG Iamgold Corporation

Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.

Share on Social Networks: